Simon Barnett Profile picture
Jan 18 10 tweets 4 min read
Now that @Quantum_Si has given us a peek under the hood of its protein #sequencing platform (Platinum), we can begin comparing actual results to theory.

A few months ago, I shared this paper that gave a theoretical framework for protein sequencing:
pubs.acs.org/doi/10.1021/ac…
The author simulated how different factors, such as the # of readable amino acids (AAs) and the read length, would affect a protein sequencer's ability to unambiguously detect the 20,000 canonical human proteins in our bodies.

That chart is attached below.
I've marked in green where QSI currently stacks up. Based on its recent pre-print (linked below), Platinum can directly read seven (7) amino acids (F, Y, W, L, I, V, and R) with peptide reads that seem to max out around 20 AAs.

biorxiv.org/content/10.110…
Based on my crude line drawings, QSI may be able to detect 19,300/20,000 proteins (~96% of total) despite only having a repertoire of 7 distinct AA recognizers. Indeed, that's about what they claim in the paper.
Of course, there are pragmatic concerns that need addressing to truly battle-test this number, namely loading efficiency (Poisson limits), dynamic range compression (Howdy, Seer!), CMOS chip density, etc.

I'll share more on these when early-access data starts accruing.
It's also interesting to see which seven AAs QSI can detect, which I've marked in the chart below. Some AAs (given their rarity) matter more when discriminating between proteins. QSI's seven seem to span the entire range from not-very to very important!
I'm eager to see just how much users can get done with the performance as it currently stands. We believe QSIs potential to read substantially all AAs (and post-translational modifications PTMs) is astounding. As such, I plan to track the company's progress ...
...as it engineers more AA recognizers (seems like a good @Ginkgo project) to round out Platinum's protein sequencing capabilities.

For targeted sequencing work, I think the potential at launch is tangible.

I'm murkier on the prospects (in the near term) for protein counting.
As others (@new299) have written, CMOS chips are quite hard to pack densely with sensors (and occupy each one with a single target molecule). As such, the overall throughput may be limited.

41j.com/blog/2021/08/q…
Even so, a technology that can detect protein variants (proteoforms) at single-molecule sensitivity even in complex mixtures is a tantalizing possibility that I'm excited to watch transition into reality.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Simon Barnett

Simon Barnett Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @sbarnettARK

Dec 16, 2021
A recent publication by Dennis Lo et al applied long-read sequencing (LRS) in the prenatal screening (#NIPT) setting. It's a rather unorthodox technology/application pairing, and it's got me scratching my head a bit.

Open Acces Link:

pnas.org/content/118/50…
For context, earlier this year, Lo et al published a convolutional neural network ("the HK model") that enabled PacBio LRS devices to read methylation (5mC) across the entire genome with very high fidelity. This is important later.

What's methylation?
PDF of HK Model Paper:
pnas.org/content/pnas/1…

I'll summarize my main takeaways from the current paper and end with some of my open questions/concerns.
Read 30 tweets
Dec 3, 2021
@MJLBio @Sanctuary_Bio @Biohazard3737 Sure! I realize I was being a little vague with those statements. Generally, I think you're correct in your interpretation of the importance of P2 (great $/GB, but at a smaller scale) as well as duplex sequencing.

Something that is important to recognize, though ...
@MJLBio @Sanctuary_Bio @Biohazard3737 ... is how product deployment works differently between PacBio and Nanopore, which is partly an artefact of culture and of time in the public markets, in the public markets. I'm not advocating for one over the other with my next statements.
@MJLBio @Sanctuary_Bio @Biohazard3737 PacBio has been a public company for a long time. While the management has changed much since the failed Illumina merger, the familiarity with how to operate as a public company has not.

PacBio is more secretive and only unveils fully built-out commercial products.
Read 5 tweets
Sep 16, 2021
I'd like to share my initial reaction to today's Berkeley Lights report. But first, I need to do some housekeeping. I can't comment on stock movements, share financial projections, or debate fair value.

Please see our general disclosure: ark-invest.com/terms/#twitter
Generally, I respect anyone who's put this much work into a topic. I won't pretend to have a clean rebuttal to every point. In my experience, beyond the hyperbole and hasty generalizations, there is some truth in these types of reports.

I want to soberly appraise those truths.
Also, I'd invite the subject-matter experts waiting in the wings to build off of this thread, add detail, or share their experiences. Ultimately, we're all after the same thing.

I will start with a few concessions and end with a few counterpoints to today's report:
Read 28 tweets
Sep 14, 2021
What is lead-time bias in #cancer screening?

Imagine that a meteor was hurtling through space towards the Earth. Its speed and trajectory indicate that it will destroy the planet in approximately 10 years.

Now, let's say that our best sensors are only ...
... capable of seeing said meteor 1 year in advance. So, 9 years go by and we are blissfully unaware of our impending doom. Then, at the 9-year mark, we detect the meteor and measure our remaining survival time to be just 1 year.
What if I gave you a better sensor? What if this sensor could see the meteor from 10 years away instead of just 1?

How long would our survival time be? While we may have a 10-year lead time instead of a 1-year lead time, the meteor still strikes us on the same day.
Read 9 tweets
Aug 17, 2021
As short-read #sequencing (SRS) costs begin to drop again, undoubtedly fueled by a resurgence in competition, I suspect many liquid biopsy providers will add blood-based whole-genome sequencing (WGS) to supplement, or replace, the deep targeted sequencing paradigm.
With a few exceptions, most clinical-stage diagnostic companies build patient-specific panels by sequencing the solid tumor, then downselecting to a few dozen mutations to survey in the bloodstream.

I don't think this approach is going anywhere anytime soon.
However useful, this deep-sequencing approach suffers from several challenges:

1. It requires access to tissue.
2. It requires the construction of patient-specific PCR panels.
3. It requires significant over-sequencing ($$$).
4. It introduces a third layer of error (PCR).
Read 14 tweets
Jun 9, 2021
We often discuss how more comprehensive and sensitive techniques improve the diagnostic yield for patients affected by rare genetic diseases. Indeed, yields have improved as we've gone from microarrays to whole genome #sequencing.

However, there's another critical component.
Case-Level Reanalysis (CLR)

By reanalyzing genomic data, as our global knowledge-base grows, we improve diagnostic yields.

We believe the broadest tests should be done first to avoid the need to re-contact and re-accession patient samples.

ncbi.nlm.nih.gov/pmc/articles/P…
The economics for both the lab (and patient) change dramatically as well in a 'generate-once-reassess-often' framework. As more is known, variant interpretation may shift from being more manual to more automated.

Still, this is a really hard technological problem.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(